Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP5322599B2 - Antioxidant - Google Patents
[go: Go Back, main page]

JP5322599B2 - Antioxidant - Google Patents

Antioxidant Download PDF

Info

Publication number
JP5322599B2
JP5322599B2 JP2008294604A JP2008294604A JP5322599B2 JP 5322599 B2 JP5322599 B2 JP 5322599B2 JP 2008294604 A JP2008294604 A JP 2008294604A JP 2008294604 A JP2008294604 A JP 2008294604A JP 5322599 B2 JP5322599 B2 JP 5322599B2
Authority
JP
Japan
Prior art keywords
extract
giraffe
added
effect
action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2008294604A
Other languages
Japanese (ja)
Other versions
JP2010120869A (en
Inventor
耕一郎 田村
和也 平田
喬 山岸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noevir Co Ltd
Original Assignee
Noevir Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noevir Co Ltd filed Critical Noevir Co Ltd
Priority to JP2008294604A priority Critical patent/JP5322599B2/en
Publication of JP2010120869A publication Critical patent/JP2010120869A/en
Application granted granted Critical
Publication of JP5322599B2 publication Critical patent/JP5322599B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

本発明は、キリンソウ抽出物を有効成分とする抗老化剤、抗炎症剤、美白剤、及び抗酸化剤に関する。   The present invention relates to an anti-aging agent, an anti-inflammatory agent, a whitening agent, and an antioxidant that contain giraffe extract as an active ingredient.

加齢、疾患、ストレス、紫外線などによるシワ、シミ、皮膚の弾力低下といった皮膚症状の要因として、乾燥、細胞機能機能低下、紫外線によるメラニン産生や色素沈着、真皮マトリックス成分の減少や変性、紫外線等による細胞の酸化障害などが挙げられる。このような皮膚症状を防止・改善するために、様々な有効成分の検索及び配合検討がなされてきた。特に天然由来成分は、様々な薬理作用や美容効果を有することが知られ、これまでにも数多くの植物や菌類などの抽出物の皮膚外用剤、経口組成物への応用が検討されてきた。   Causes of skin symptoms such as aging, disease, stress, UV wrinkles, stains, reduced skin elasticity, dryness, decreased cellular function, melanin production and pigmentation due to UV rays, decrease and degeneration of dermal matrix components, UV rays, etc. Oxidative damage of cells due to. In order to prevent and ameliorate such skin symptoms, various active ingredients have been searched and formulated. In particular, naturally-derived components are known to have various pharmacological and cosmetic effects, and the application of extracts such as plants and fungi to skin external preparations and oral compositions has been studied so far.

例えば、皮膚の保湿効果と安全性に優れた保湿剤としてハリブキ属植物の抽出物(特許文献1参照)、皮膚の老化防止、改善作用を有する皮膚外用剤を得るために、真皮線維芽細胞の賦活あるいは増殖促進作用を有する成分としてポンカンのエッセンス(特許文献2参照)、ツリガネニンジン属植物の抽出物(特許文献3参照)、クロレラ抽出物(特許文献4参照)、ビワ抽出物(特許文献5参照)等が開示されている。美白剤としては、白鶴霊芝の抽出物(特許文献6参照)等が、抗酸化剤としてはサルオガセ科サルオガセ属植物の抽出物(特許文献7参照)等が、生体内の脂肪蓄積を抑制する成分としては、哺乳動物の乳由来リン脂質(特許文献8参照)、褐藻の酵素分解物(特許文献9参照)等がそれぞれすでに知られている。   For example, in order to obtain an extract of a plant belonging to the genus Halibut (see Patent Document 1) as a moisturizing agent excellent in skin moisturizing effect and safety, and to obtain a skin external preparation having an anti-aging and improving action on the skin, The essence of Ponkan as a component having an activation or growth promoting action (see Patent Document 2), an extract of plants belonging to the genus Genus ginseng (see Patent Document 3), a chlorella extract (see Patent Document 4), and a loquat extract (see Patent Document 5) ) Etc. are disclosed. As a whitening agent, an extract of white crane reishi (see Patent Document 6) and the like, and as an antioxidant, an extract of a plant belonging to the genus Sarogase (see Patent Document 7) and the like suppress fat accumulation in the living body. As components, mammalian milk-derived phospholipids (see Patent Literature 8), brown algal enzyme degradation products (see Patent Literature 9) and the like are already known.

特開2007−77072号公報JP 2007-77072 A 特開2001−131045号公報JP 2001-131045 A 特開2000−178198号公報JP 2000-178198 A 特開平11−335293号公報JP 11-335293 A 特公平5−17206号公報Japanese Patent Publication No. 5-17206 特開2003−89630号公報JP 2003-89630 A 特開平10−182413号公報Japanese Patent Laid-Open No. 10-182413

このように、これまでに様々な天然由来成分が応用されている。しかし、天然由来成分の中には、未だその効果が知られていないものも数多く存在し、優れた抗老化作用、抗酸化作用、及び美白作用を有する有効成分の開発が期待されていた。   Thus, various naturally-derived components have been applied so far. However, there are many naturally-derived components whose effects are not yet known, and the development of active ingredients having excellent anti-aging, antioxidant, and whitening effects has been expected.

本発明者らは、天然由来の種々の成分について検討を行った結果、キリンソウ抽出物に優れた抗老化作用、抗炎症作用、美白作用、及び抗酸化作用が存在することを見出し、さらに検討を重ねて本発明を完成させるに至った。   As a result of examining various components derived from nature, the present inventors have found that an excellent anti-aging action, anti-inflammatory action, whitening action, and antioxidant action are present in giraffe extract, and further investigation is made. Over time, the present invention has been completed.

すなわち、本発明は、キリンソウ抽出物を有効成分とする抗老化剤、抗炎症剤、美白剤、及び抗酸化剤に関する。   That is, the present invention relates to an anti-aging agent, an anti-inflammatory agent, a whitening agent, and an antioxidant that contain giraffe extract as an active ingredient.

本発明によれば、キリンソウ抽出物を有効成分とすることにより、優れた効果を有する抗老化剤、抗炎症剤、美白剤、及び抗酸化剤を提供することができる。   ADVANTAGE OF THE INVENTION According to this invention, the anti-aging agent, anti-inflammatory agent, whitening agent, and antioxidant which have the outstanding effect can be provided by using giraffe extract as an active ingredient.

これらの抗老化剤、抗炎症剤、美白剤、及び抗酸化剤を皮膚外用剤および経口組成物に配合することにより、シワ、タルミ、皮膚の弾力低下、シミ、くすみいった種々の皮膚症状の発現防止や改善に優れた効果を発揮する、様々な組成物を提供することができる。   By blending these anti-aging agents, anti-inflammatory agents, whitening agents, and antioxidants into skin external preparations and oral compositions, various skin symptoms such as wrinkles, tarmi, reduced skin elasticity, spots and dullness can be obtained. Various compositions that exhibit an excellent effect in preventing and improving expression can be provided.

本発明で用いるキリンソウは、ベンケイソウ科マンネングサ属に属する双子葉植物であり、九州から北海道に分布し、変異種も多く見られる。本発明においては、キリンソウであれば特に限定されない。キリンソウの学名は、Sedum kamtschaticum Fisch.、Sedum aizoon L.、Sedum aizoon L. var. floribundum Nakaiである。
The giraffe used in the present invention is a dicotyledonous plant belonging to the genus Amanengusa, distributed from Kyushu to Hokkaido, and has many mutant species. In the present invention, the giraffe is not particularly limited. Manabu name of Kirinsou is, Sedum kamtschaticum Fisch., Sedum aizoon L., Sedum aizoon L. var. Ru floribundum Naka i der.

これらキリンソウを使用する際は、その使用部位には特に制限はなく、葉、茎、花、根などの任意の部分を使用することができる。複数の部位を組み合わせて使用してもよい。   When these giraffes are used, there are no particular restrictions on the site of use, and any part such as leaves, stems, flowers, roots, etc. can be used. A plurality of parts may be used in combination.

抽出の際は、キリンソウを生のまま用いてもよいが、抽出効率を考えると、細切、乾燥、粉砕等の処理を行った後に抽出を行うことが好ましい。   In the extraction, giraffe may be used as it is, but considering the extraction efficiency, it is preferable to perform the extraction after processing such as shredding, drying, and pulverization.

抽出は、任意の抽出溶媒に所定時間浸漬して行うことができる。抽出溶媒は、必要に応じて加熱してもよい。あるいは、超臨界流体や亜臨界流体を用いた抽出方法でも行うことができる。抽出効率を上げるため、撹拌したり抽出溶媒中でホモジナイズしたりしてもよい。抽出温度としては、5℃程度から抽出溶媒の沸点以下の温度とするのが適切である。抽出時間は、抽出溶媒の種類や抽出温度によっても異なるが、1時間〜14日間程度とするのが適切である。   The extraction can be performed by immersing in an arbitrary extraction solvent for a predetermined time. The extraction solvent may be heated as necessary. Alternatively, extraction can be performed using a supercritical fluid or a subcritical fluid. In order to increase the extraction efficiency, stirring or homogenization in an extraction solvent may be performed. The extraction temperature is suitably about 5 ° C. to the boiling point of the extraction solvent. The extraction time varies depending on the type of extraction solvent and the extraction temperature, but is suitably about 1 hour to 14 days.

抽出溶媒としては、水の他、メタノール、エタノール、プロパノール、イソプロパノール等の低級アルコール;1,3−ブチレングリコール、プロピレングリコール、ジプロピレングリコール、グリセリン等の多価アルコール;エチルエーテル、プロピルエーテル等のエーテル類;酢酸ブチル、酢酸エチル等のエステル類;アセトン、エチルメチルケトン等のケトン類などの溶媒を用いることができる。これらは、単独で用いられるほか、任意の2種以上を組み合わせて用いてもよい。生理食塩水、リン酸緩衝液、リン酸緩衝生理食塩水等を用いてもよい。さらに、水や二酸化炭素、エチレン、プロピレン、エタノール、メタノール、アンモニアなどの1種又は2種以上の超臨界液体や亜臨界液体を用いてもよい。   As an extraction solvent, in addition to water, lower alcohols such as methanol, ethanol, propanol and isopropanol; polyhydric alcohols such as 1,3-butylene glycol, propylene glycol, dipropylene glycol and glycerin; ethers such as ethyl ether and propyl ether Solvents such as esters; esters such as butyl acetate and ethyl acetate; ketones such as acetone and ethyl methyl ketone can be used. These may be used alone or in combination of any two or more. Saline, phosphate buffer, phosphate buffered saline, and the like may be used. Furthermore, you may use 1 type, or 2 or more types of supercritical liquids and subcritical liquids, such as water, a carbon dioxide, ethylene, propylene, ethanol, methanol, ammonia.

キリンソウの上記溶媒による抽出物は、そのままでも使用することができるが、一定期間そのまま静置して熟成させて用いてもよいし、濃縮、乾固した物を水や極性溶媒に再度溶解して使用することもできる。或いは、これらの生理作用を損なわない範囲で、脱色、脱臭、脱塩等の精製処理や、カラムクロマトグラフィー等による分画処理を行った後に用いてもよい。キリンソウの前記抽出物やその処理物及び分画物は、各処理及び分画後に凍結乾燥し、用時に溶媒に溶解して用いることもできる。また、リポソーム等のベシクルやマイクロカプセル等に内包させて用いることもできる。   The above extract of giraffe with the above solvent can be used as it is, but it may be left standing for a certain period of time and aged, or the concentrated and dried product may be dissolved again in water or a polar solvent. It can also be used. Alternatively, it may be used after performing purification treatment such as decolorization, deodorization, desalting, etc., or fractionation treatment by column chromatography or the like, as long as these physiological functions are not impaired. The above-mentioned extract of giraffe and its treated and fractionated products can be freeze-dried after each treatment and fractionation and dissolved in a solvent before use. It can also be used by encapsulating in vesicles such as liposomes or microcapsules.

キリンソウ抽出物は、優れた抗老化作用、抗炎症作用、美白作用、抗酸化作用を有し、抗老化剤、抗炎症剤、美白剤、抗酸化剤として利用することができる。   Giraffe extract has excellent anti-aging action, anti-inflammatory action, whitening action, and antioxidant action, and can be used as an anti-aging agent, anti-inflammatory agent, whitening agent, and antioxidant.

キリンソウ抽出物を有効成分とする抗老化剤は、優れたヒト真皮線維芽細胞の細胞賦活効果、真皮線維芽細胞におけるI型コラーゲン産生促進効果を有し、老化症状の防止・改善に優れた効果を発揮する。   Anti-aging agent containing giraffe extract as an active ingredient has excellent cell activation effect of human dermal fibroblasts, type I collagen production promotion effect in dermal fibroblasts, and excellent effect in preventing and improving aging symptoms Demonstrate.

キリンソウ抽出物を有効成分とする抗炎症剤は、優れたヒアルロニダーゼ阻害効果を有し、炎症の防止・改善に優れた効果を発揮する。   An anti-inflammatory agent containing giraffe extract as an active ingredient has an excellent hyaluronidase inhibitory effect, and exhibits an excellent effect in preventing and improving inflammation.

キリンソウ抽出物を有効成分とする美白剤は、優れたメラニン産生抑制効果を有し、色素沈着、シミ、そばかす等を予防および改善して、優れた美白作用を発揮する。   A whitening agent containing giraffe extract as an active ingredient has an excellent inhibitory effect on melanin production, and prevents and improves pigmentation, blemishes, freckles, etc., and exhibits an excellent whitening effect.

キリンソウ抽出物を有効成分とする抗酸化剤は、優れたラジカル消去効果、スーパーオキサイドアニオン消去効果を有し、優れた抗酸化作用を発揮する。   An antioxidant containing giraffe extract as an active ingredient has an excellent radical scavenging effect and a superoxide anion scavenging effect, and exhibits an excellent antioxidant action.

[抽出物1]
キリンソウの地上部位を乾燥させて粉砕し、サンプル質量の20倍量の精製水を加え、オートクレーブにより20分間、120℃に加温して抽出した。得られた抽出液から、温度の高い状態を保ちながら吸引濾過により不溶物を取り除いた後、凍結乾燥を行い、キリンソウの熱水抽出物(抽出物1)を得た。
[Extract 1]
The ground part of giraffe was dried and pulverized, purified water of 20 times the mass of the sample was added, and the mixture was extracted by heating to 120 ° C. for 20 minutes with an autoclave. From the obtained extract, insoluble matters were removed by suction filtration while maintaining a high temperature state, followed by freeze-drying to obtain a hot water extract of Giraffe (Extract 1).

[抽出物2]
キリンソウの地上部位を乾燥させて粉砕し、サンプル質量の20倍量の50質量%エタノールを加え、室温で撹拌しながら2時間抽出した。得られた抽出液を濾過して不溶物を取り除き、減圧濃縮後、凍結乾燥を行って、キリンソウのエタノール抽出物(抽出物2)を得た。
[Extract 2]
The above-ground part of giraffe was dried and pulverized, 50% by mass of 20 times the mass of the sample was added, and extracted for 2 hours while stirring at room temperature. The obtained extract was filtered to remove insoluble matters, concentrated under reduced pressure, and freeze-dried to obtain an ethanol extract of giraffe (extract 2).

上記抽出物を用いて、各効果の評価を行った。なお各評価結果に記載した*及び**は、t検定における有意確率P値に対し、有意確率5%未満(P<0.05)を*で、有意確率1%未満(P<0.01)を**でそれぞれ表したものである。   Each effect was evaluated using the said extract. Note that * and ** described in each evaluation result indicate that the significance probability P value in the t-test is less than 5% (P <0.05) with a significance probability of *, and less than 1% significance probability (P <0.01). ) Is represented by **.

[真皮線維芽細胞賦活作用]
正常ヒト真皮繊維芽細胞を1ウェル当り2.0×10個となるように96ウェルマイクロプレートに播種した。播種培地にはダルベッコ改変イーグル培地(DMEM)に1質量%のウシ胎児血清(FBS)を添加したものを用いた。24時間後、1質量%FBS添加DMEM培地にて各濃度に調整した抽出物1を含有するサンプル培養液に交換しさらに48時間培養した。次にMTT試薬を400μg/mLとなるように培地にて調整し、上清を除いた細胞に添加し約2時間培養した。最後に2−プロパノールにて生じたフォルマザンを抽出し、マイクロプレートリーダーにて550nmの吸光度を測定した。同時に濁度として650nmの吸光度を測定し、両測定値の差を用いて細胞賦活作用を評価した。評価は抽出物1無添加時のコントロールにおける細胞賦活作用を100とした時の相対値を求めて行い結果を表1に示す。
[Dermal fibroblast activation]
Normal human dermal fibroblasts were seeded in a 96-well microplate at 2.0 × 10 4 cells per well. The seeding medium used was Dulbecco's modified Eagle medium (DMEM) supplemented with 1% by weight fetal bovine serum (FBS). After 24 hours, the culture medium was replaced with a sample culture solution containing the extract 1 adjusted to each concentration in 1% by mass FBS-added DMEM medium, and further cultured for 48 hours. Next, the MTT reagent was adjusted in the medium to 400 μg / mL, added to the cells from which the supernatant was removed, and cultured for about 2 hours. Finally, formazan produced in 2-propanol was extracted, and the absorbance at 550 nm was measured with a microplate reader. At the same time, the absorbance at 650 nm was measured as turbidity, and the cell activation effect was evaluated using the difference between the two measured values. Evaluation was carried out by obtaining a relative value when the cell activation effect in the control when no extract 1 was added was taken as 100, and the results are shown in Table 1.

Figure 0005322599
Figure 0005322599

結果は、表1に示した通りであり、キリンソウ抽出物は、有意な真皮線維芽細胞賦活作用を示した。   The results are as shown in Table 1, and the giraffe extract showed a significant dermal fibroblast activation effect.

[真皮線維芽細胞I型コラーゲン産生促進作用]
正常ヒト真皮繊維芽細胞を1ウェル当り2.0×10個となるように96ウェルマイクロプレートに播種した。播種培地にはダルベッコ改変イーグル(DMEM)培地に5質量%のウシ胎児血清(FBS)を添加したものを用いた。24時間後、0.5質量%FBS添加DMEM培地にて各濃度に調整した抽出物2を含有するサンプル培養液に交換しさらに24時間培養した。
培養上清中に分泌されたタイプ1コラーゲン量はELISA法を用い、最後は標識されたペルオキシダーゼに対し2、2’−アジノビス(3−エチルベンゾチアゾリン−6−スルホン酸)ジアンモニウム塩(ABTS)及び過酸化水素を添加し反応させた後、マイクロプレートリーダーにて405nmの吸光度を測定した。評価ではサンプル培養液の他にネガティブコントロールとして0.5%FBS添加DMEM培地を用いた。
評価は抽出物無添加時の細胞賦活作用を100とした時の相対値を求めて行った。具体的には、PIERCE社製BCA Protein Assay Kitにてタンパク量を測定し単位細胞又は単位タンパク量当りのコラーゲン産生量を求め、ネガティブコントロールの単位当りI型コラーゲン産生量を100とした時の相対値を求めた。
[Dermal fibroblast type I collagen production promoting effect]
Normal human dermal fibroblasts were seeded in a 96-well microplate at 2.0 × 10 4 cells per well. The seeding medium used was Dulbecco's modified Eagle (DMEM) medium supplemented with 5% by weight fetal bovine serum (FBS). After 24 hours, the culture medium was replaced with a sample culture solution containing the extract 2 adjusted to each concentration in a DMEM medium supplemented with 0.5 mass% FBS, and further cultured for 24 hours.
The amount of type 1 collagen secreted into the culture supernatant was determined by ELISA, and finally 2,2′-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) against labeled peroxidase. And after adding hydrogen peroxide and making it react, the light absorbency of 405 nm was measured with the microplate reader. In the evaluation, in addition to the sample culture solution, a DMEM medium supplemented with 0.5% FBS was used as a negative control.
The evaluation was performed by obtaining a relative value when the cell activation effect when no extract was added was taken as 100. Specifically, the amount of protein was determined by measuring the amount of protein with BCA Protein Assay Kit manufactured by PIERCE, and the amount of collagen production per unit cell or unit protein was calculated. The value was determined.

Figure 0005322599
Figure 0005322599

結果は、表2に示した通りであり、キリンソウ抽出物は、有意な真皮線維芽細胞I型コラーゲン産生促進作用を示した。   The results are as shown in Table 2. The giraffe extract showed a significant dermal fibroblast type I collagen production promoting action.

表1及び表2に示したとおり、キリンソウ抽出物は高い真皮線維芽細胞賦活作用及び真皮線維芽細胞I型コラーゲン産生促進作用を有し、抗老化効果を発揮する。   As shown in Tables 1 and 2, the giraffe extract has a high dermal fibroblast activation action and dermal fibroblast type I collagen production promoting action, and exhibits an anti-aging effect.

[ヒアルロニダーゼ阻害作用]
市販のヒアルロン酸カリウム塩(ヒト臍の緒由来)を0.9mg/mLになるように、0.1Mリン酸緩衝液(pH7.0)に溶解し、基質溶液とした。市販のヒアルロニダーゼ(ウシ精巣由来)を5,3000unit/mLとなるように、0.1Mリン酸緩衝液(pH7.0)に溶解し、酵素溶液とした。なお酵素溶液は用時調製とした。試験管に、緩衝液で各濃度に調製した抽出物2含有溶液0.1mL、及び酵素溶液0.03mLをとり、37℃で20分間反応させた。次に活性化剤を0.06mL加え、37℃で20分間反応させた。さらに基質溶液を0.15mL加え、37℃で1時間反応させた。0.4規定のNaOHを0.06mL加え反応を停止させた後すぐに氷冷し、ホウ酸緩衝液(pH9.1)を0.06mL添加し、3分間煮沸した後さらに氷冷した。p−ジメチルベンズアルデヒド(p−DABA)溶液溶液を2.0mL添加し、37℃で20分間反応させた後、各試験管から96ウェルマイクロプレートに移しかえ、マイクロプレートリーダーを用いて585nmにおける吸光度を測定した。コントロールには、抽出物無添加の緩衝溶液のみを加えたものを用いた。ヒアルロニダーゼの活性が阻害されると分解産物であるN−アセチルグルコサミンが減少し。p−DABAによる吸光度が低くなる。このことを利用し、阻害活性は次式より求めた。結果を表3にまとめる。
阻害率(%)=(コントロール吸光度−サンプル吸光度)/コントロール吸光度×100
[Hyaluronidase inhibitory action]
Commercially available hyaluronic acid potassium salt (derived from human umbilical cord) was dissolved in 0.1 M phosphate buffer (pH 7.0) to a concentration of 0.9 mg / mL to obtain a substrate solution. A commercially available hyaluronidase (derived from bovine testis) was dissolved in 0.1 M phosphate buffer (pH 7.0) so as to be 5,3000 units / mL to obtain an enzyme solution. The enzyme solution was prepared at the time of use. In a test tube, 0.1 mL of the extract 2-containing solution prepared at each concentration with a buffer solution and 0.03 mL of the enzyme solution were taken and reacted at 37 ° C. for 20 minutes. Next, 0.06 mL of an activator was added and reacted at 37 ° C. for 20 minutes. Further, 0.15 mL of the substrate solution was added and reacted at 37 ° C. for 1 hour. 0.06 mL of 0.4N NaOH was added to stop the reaction, and the mixture was immediately cooled with ice. Then, 0.06 mL of borate buffer (pH 9.1) was added, and the mixture was boiled for 3 minutes and further cooled with ice. After 2.0 mL of p-dimethylbenzaldehyde (p-DABA) solution was added and reacted at 37 ° C. for 20 minutes, the solution was transferred from each test tube to a 96-well microplate, and the absorbance at 585 nm was measured using a microplate reader. It was measured. As a control, a solution to which only an extract-free buffer solution was added was used. When the activity of hyaluronidase is inhibited, the degradation product N-acetylglucosamine decreases. Absorbance by p-DABA is lowered. Utilizing this fact, the inhibitory activity was obtained from the following equation. The results are summarized in Table 3.
Inhibition rate (%) = (control absorbance−sample absorbance) / control absorbance × 100

Figure 0005322599
Figure 0005322599

表3に示したとおり、キリンソウ抽出物はヒアルロニダーゼ阻害作用を有し、抗炎症効果を発揮する。   As shown in Table 3, the giraffe extract has a hyaluronidase inhibitory action and exhibits an anti-inflammatory effect.

[メラニン産生抑制作用]
B16マウスメラノーマ細胞を90mmディッシュ1ディッシュ当り1.8×10個となるように播種し、5質量%のウシ胎児血清(FBS)を添加したダルベッコ改変イーグル培地(DMEM)を用いて培養した。24時間後に5質量%FBS添加DMEM培地に試料を添加して各濃度に調整した抽出物2を含有する培養液に交換した。さらに5日間培養し、培養終了後にトリプシンにより細胞を剥離して回収した。回収した細胞を遠心し、細胞沈殿物を得た。得られた沈殿物は下記に示した判定基準によりその黒化状況を目視で判定した。評価では、抽出物2を添加せず5質量%FBS添加DMEM培地のみで培養し、ネガティブコントロールとし、抽出物2のかわりに50mM乳酸ナトリウムを添加して培養し、ポジティブコントロールとした。
評価基準
判定1:ポジティブコントロールと同程度(ほぼ白色)
判定2:ポジティブコントロールより僅かに黒い(薄い褐色)
判定3:ポジティブコントロールとネガティブコントロールの中間(褐色)
判定4:ネガティブコントロールより僅かに白い(黒褐色)
判定5:ネガティブコントロールと同程度(ほぼ黒色)
[Inhibition of melanin production]
B16 mouse melanoma cells were seeded at 1.8 × 10 4 per 90 mm dish, and cultured using Dulbecco's modified Eagle medium (DMEM) supplemented with 5% by mass of fetal bovine serum (FBS). After 24 hours, the sample was added to 5% by mass FBS-added DMEM medium, and the medium was replaced with a culture solution containing the extract 2 adjusted to each concentration. After further culturing for 5 days, the cells were detached and collected with trypsin after completion of the culture. The collected cells were centrifuged to obtain a cell precipitate. The resulting precipitate was visually judged for its blackening condition according to the criteria shown below. In the evaluation, the extract 2 was not added and cultured in only 5% by mass FBS-added DMEM medium as a negative control, and 50 mM sodium lactate was added instead of the extract 2 and cultured as a positive control.
Evaluation criteria judgment 1: Same as positive control (almost white)
Judgment 2: Slightly blacker than the positive control (light brown)
Judgment 3: Between positive control and negative control (brown)
Judgment 4: Slightly whiter than the negative control (blackish brown)
Judgment 5: Same as negative control (almost black)

Figure 0005322599
Figure 0005322599

結果は、表4に示した通りであり、キリンソウ抽出物は、明らかなメラニン産生抑制作用を示し、美白作用を発揮する。   The results are as shown in Table 4. The giraffe extract exhibits a clear melanin production inhibitory effect and exhibits a whitening effect.

[DPPHラジカル消去作用]
抽出物2を50質量%エタノール水溶液を用いて各濃度に調整し、96ウェルマイクロプレートに100μLずつ添加した。さらに0.2mMの1,1−ジフェニル−2−ピクリルヒドラジル(DPPH)エタノール溶液を100μLずつ添加し、充分に混合後室温、暗所にて24時間静置後、516nmの吸光度を測定した。抽出物2無添加のブランクの吸光度を(A)、抽出物2を添加したときの吸光度を(B)としたとき、次式(2)の値をラジカル消去率とした。
DPPHラジカル消去率={1−(B)/(A)}×100(%) (2)
[DPPH radical scavenging action]
Extract 2 was adjusted to each concentration using a 50% by mass aqueous ethanol solution, and 100 μL was added to each 96-well microplate. Further, 100 μL each of 0.2 mM 1,1-diphenyl-2-picrylhydrazyl (DPPH) ethanol solution was added, mixed well, allowed to stand at room temperature in the dark for 24 hours, and the absorbance at 516 nm was measured. . When the absorbance of the blank with no extract 2 added is (A) and the absorbance when the extract 2 is added is (B), the value of the following formula (2) is defined as the radical elimination rate.
DPPH radical scavenging rate = {1- (B) / (A)} × 100 (%) (2)

Figure 0005322599
Figure 0005322599

結果は、表5に示した通りであり、キリンソウ抽出物は、明らかなDPPHラジカル消去作用を示した。   The results are as shown in Table 5, and the giraffe extract showed a clear DPPH radical scavenging action.

[SOD様活性作用]
0.25mM WST−1及び1mMハイポキサンチンを含有するHANK’S(+)溶液75μLに、抽出物2をHANK’S(+)溶液を用いて各濃度に調整したサンプル溶液25μLを添加する。さらに、キサンチンオキシダーゼ25μL(0.0075ユニット)を添加し、37℃で15分間反応させた後、450nmの吸光度を測定した。サンプル溶液に替えてHANK’S(+)溶液のみを添加した場合の吸光度を(A)、サンプル溶液を添加した場合の吸光度を(B)としたとき、スーパーオキサイドアニオン消去率は次式(3)によって求めた。スーパーオキサイドアニオン消去率(%)=[1−(B)/(A)]×100 (3)
[SOD-like activity]
To 75 μL of the HANK ′S (+) solution containing 0.25 mM WST-1 and 1 mM hypoxanthine, 25 μL of the sample solution prepared by adjusting the extract 2 to each concentration using the HANK ′S (+) solution is added. Further, 25 μL (0.0075 units) of xanthine oxidase was added and reacted at 37 ° C. for 15 minutes, and then the absorbance at 450 nm was measured. When the absorbance when only the HANK'S (+) solution is added instead of the sample solution is (A) and the absorbance when the sample solution is added is (B), the superoxide anion elimination rate is expressed by the following formula (3) ). Superoxide anion elimination rate (%) = [1- (B) / (A)] × 100 (3)

Figure 0005322599
Figure 0005322599

結果は、表12に示した通りであり、キリンソウ抽出物は、明らかなスーパーオキサイドアニオン消去作用を示した。   The results are as shown in Table 12, and the giraffe extract showed a clear superoxide anion scavenging action.

表11、表12に示したとおり、キリンソウ抽出物はDPPHラジカル消去効果、スーパーオキサイドアニオン消去効果を有し、抗酸化作用を発揮する。   As shown in Tables 11 and 12, the giraffe extract has a DPPH radical scavenging effect and a superoxide anion scavenging effect, and exhibits an antioxidant action.

Claims (1)

キリンソウ(Sedum kamtschaticum Fisch.、Sedum aizoon L.、Sedum aizoon L. var. floribundum Nakai)抽出物を有効成分とする抗酸化剤。 An antioxidant containing an extract of giraffe (Sedum kamtschaticum Fisch., Sedum aizoon L., Sedum aizoon L. var. Floribundum Nakai) as an active ingredient.
JP2008294604A 2008-11-18 2008-11-18 Antioxidant Active JP5322599B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008294604A JP5322599B2 (en) 2008-11-18 2008-11-18 Antioxidant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008294604A JP5322599B2 (en) 2008-11-18 2008-11-18 Antioxidant

Publications (2)

Publication Number Publication Date
JP2010120869A JP2010120869A (en) 2010-06-03
JP5322599B2 true JP5322599B2 (en) 2013-10-23

Family

ID=42322535

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008294604A Active JP5322599B2 (en) 2008-11-18 2008-11-18 Antioxidant

Country Status (1)

Country Link
JP (1) JP5322599B2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101333516B1 (en) * 2011-06-16 2013-11-28 주식회사 에스앤텍 An antibacterial and antioxidant composition using sedum extract
KR101519417B1 (en) 2013-06-25 2015-05-12 한국콜마주식회사 Cosmetic Composition Comprising Sedum polytrichoides Hemsl. Extract for Skin Whitening
JP6281761B2 (en) * 2013-10-29 2018-02-21 日本メナード化粧品株式会社 External preparation or internal preparation containing Hidakami Sebaya extract
KR101637167B1 (en) * 2014-03-14 2016-07-07 주식회사 다인소재 Antibacterials composition comprising Sedum extract composition and food additives and preparation method thereof
JP6097958B2 (en) * 2014-09-02 2017-03-22 株式会社エスジー・ワーム生命科学研究所 Manufacturing method for cosmetics
KR101704539B1 (en) * 2015-05-20 2017-02-09 한국과학기술연구원 Composition for anti-allergy and skin hydration comprising sedum kamtschaticum extracts
WO2018216835A1 (en) * 2017-05-26 2018-11-29 Dyne Soze Co., Ltd Composition for skin whitening or for preventing and alleviating skin hyperpigmentation disorder comprising compound isolated from sedum takesimense as effective ingredient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0177018B1 (en) * 1996-04-17 1999-03-20 손경식 Skin whitening cosmetic composition
JP4057170B2 (en) * 1998-11-16 2008-03-05 一丸ファルコス株式会社 Cosmetic composition containing moisturizing plant extract
KR100470158B1 (en) * 2001-12-05 2005-03-08 주식회사한국파마 An extract of Sedum kamtschaticum Fisch. and a chemical compound isolated from the extract, and a pharmaceutical composition for anti-inflammatory containing them as an effective constituents
CN100443001C (en) * 2006-06-30 2008-12-17 张学海 Health tea drink of Aizoon stonecrop herb

Also Published As

Publication number Publication date
JP2010120869A (en) 2010-06-03

Similar Documents

Publication Publication Date Title
JP5322599B2 (en) Antioxidant
KR100844516B1 (en) Cosmetic composition containing Astragalus extract
CN103565699B (en) A kind of black Fructus Lycii freckle removing and whitening defying age essence and preparation method thereof
KR101885195B1 (en) Cosmetic Composition with Fermentative Extract of Osmanthus fragrans
JP5889546B2 (en) Hexosaminidase release inhibitor, stem cell growth factor mRNA expression increase inhibitor, hydrogen peroxide cell disorder preventive / ameliorating agent and glutathione production promoter
KR20210144725A (en) Anti-aging, antioxidant, anti-inflammatory and whitening agents, and cosmetics
KR20110083480A (en) Free radical scavengers, radical scavengers and oxidative cell disorder inhibitors
JP5610681B2 (en) Neutral fat accumulation inhibitor
KR101661545B1 (en) Cosmetic composition comprising an extracts of fermented rhodiola rosea having whitening activits
KR20140052127A (en) Skin wrinkle improving cosmetic compositions containing enzymaticallly hydrolyzed apple extract
KR101639578B1 (en) Cosmetic composition containing Ocimum basilicum seed extract
KR20210064818A (en) Cosmetic composition containing lactic acid bacteria fermentation of chrysanthemum and magnolia extracted with YU SEONG hot spring water
JP2009143849A (en) Anti-aging agent, skin whitening agent, antioxidant, anti-inflammatory agent, and humectant
JP5610913B2 (en) Anti-aging agent, whitening agent, antioxidant, slimming agent, anti-inflammatory agent
JP5229728B2 (en) Arginase activity promoter, immunostimulant, anti-aging agent, whitening agent, antioxidant, and slimming agent
KR20120032690A (en) Cosmetic composition with the immunoprotective effect
JP2012041285A (en) Anti-aging agent, anti-oxidant, arginase activity accelerator, slimming agent, bleaching agent, and anti-inflammatory agent
KR20180050624A (en) Method for removing chlorophyll and pigments from plant extracts
CN118871089A (en) Protein hydrolysate of adzuki bean and its beauty application
JPH11147833A (en) Collagenase inhibitor
JP5247548B2 (en) Moisturizer, anti-aging agent, neutral fat accumulation inhibitor, whitening agent, anti-inflammatory agent, topical skin preparation, oral preparation
JP5769448B2 (en) DNA repair promoter and skin external preparation
JP2009143833A (en) Extract of crude drug and skin external preparation having the same as active ingredient
JP2012097028A (en) Anti-aging agent, anti-oxidant, arginase activity accelerator, slimming agent and whitening agent
JP7828635B2 (en) A topical and internal skin preparation containing an extract of Sanguisorba officinalis cultivated under irradiation with light having a specific wavelength range.

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110823

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20121203

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130507

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130510

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130604

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130611

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130716

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130716

R150 Certificate of patent or registration of utility model

Ref document number: 5322599

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250